Inventor · disambiguated record
Fengmei Zheng
Also filed as: ZHENG FENGMEI
5 granted patents·2 pending applications·12 citations·filing 2016–2023
75Inventor score
Files withBIOGEN MA INC7
Top patents by PatentIndex Score
7 records- 0193US11427577B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2021·Granted Aug 30, 2022·2 cites·9 claims
- 0292US10961237B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Mar 30, 2021·4 cites·6 claims
- 0389US10189829B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·6 cites·8 claims
- 0482US11858926B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Granted Jan 2, 2024·0 cites·5 claims
- 0558US2025304586A1Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamideBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 0656US11820760B2Crystalline polymorphs of Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2019·Granted Nov 21, 2023·0 cites·31 claims
- 0734US2018289655A1Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological DiseasesBIOGEN MA INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →